402 related articles for article (PubMed ID: 19594786)
21. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.
Wood E; Li K; Palepu A; Marsh DC; Schechter MT; Hogg RS; Montaner JS; Kerr T
Subst Use Misuse; 2005; 40(8):1153-67. PubMed ID: 16040375
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of a heroin overdose prevention and education campaign.
Horyniak D; Higgs P; Lewis J; Winter R; Dietze P; Aitken C
Drug Alcohol Rev; 2010 Jan; 29(1):5-11. PubMed ID: 20078676
[TBL] [Abstract][Full Text] [Related]
23. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
[TBL] [Abstract][Full Text] [Related]
24. Equitable access to dental care for an at-risk group: a review of services for Australian refugees.
Davidson N; Skull S; Calache H; Chesters D; Chalmers J
Aust N Z J Public Health; 2007 Feb; 31(1):73-80. PubMed ID: 17333613
[TBL] [Abstract][Full Text] [Related]
25. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
Appel PW; Oldak R
Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
[TBL] [Abstract][Full Text] [Related]
26. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
[TBL] [Abstract][Full Text] [Related]
27. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
28. Use of a medically supervised injection facility among street youth.
Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
[TBL] [Abstract][Full Text] [Related]
29. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
[TBL] [Abstract][Full Text] [Related]
30. A description of a peer-run supervised injection site for injection drug users.
Kerr T; Oleson M; Tyndall MW; Montaner J; Wood E
J Urban Health; 2005 Jun; 82(2):267-75. PubMed ID: 15872193
[TBL] [Abstract][Full Text] [Related]
31. Patient perspectives on primary health care in rural communities: effects of geography on access, continuity and efficiency.
Wong ST; Regan S
Rural Remote Health; 2009; 9(1):1142. PubMed ID: 19298094
[TBL] [Abstract][Full Text] [Related]
32. Public injection settings in Vancouver: physical environment, social context and risk.
Small W; Rhodes T; Wood E; Kerr T
Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
[TBL] [Abstract][Full Text] [Related]
33. Access barriers to substance abuse treatment for persons with disabilities: an exploratory study.
Krahn G; Farrell N; Gabriel R; Deck D
J Subst Abuse Treat; 2006 Dec; 31(4):375-84. PubMed ID: 17084791
[TBL] [Abstract][Full Text] [Related]
34. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
[TBL] [Abstract][Full Text] [Related]
35. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
[TBL] [Abstract][Full Text] [Related]
36. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
37. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention.
Knowlton AR; Hua W; Latkin C
AIDS Care; 2005 May; 17(4):479-92. PubMed ID: 16036234
[TBL] [Abstract][Full Text] [Related]
38. Harm minimization strategies: opinions of health professionals in rural and remote Australia.
Peterson GM; Northeast S; Jackson SL; Fitzmaurice KD
J Clin Pharm Ther; 2007 Oct; 32(5):497-504. PubMed ID: 17875117
[TBL] [Abstract][Full Text] [Related]
39. Access to treatment-related and support services in methadone treatment programs.
Berkman ND; Wechsberg WM
J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
[TBL] [Abstract][Full Text] [Related]
40. My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
Green TC; Hankins CA; Palmer D; Boivin JF; Platt R
Can J Public Health; 2004; 95(2):110-4. PubMed ID: 15074900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
